Pharmaceuticals

Latest KFF Health News Stories

Interactive: How Orphan Drugs Win The ‘Monopoly’ Game

KFF Health News Original

Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.

A Peer Recovery Coach Walks The Frontlines Of The Opioid Epidemic

KFF Health News Original

Charlie Oen was addicted to heroin as a teenager. At 25, he’s now clean and a peer counselor in Lima, Ohio, where he tries to help people who started using drugs before he was born.

Los ganadores y los perdedores del 21st Century Cures Act

KFF Health News Original

El 21st Century Cures Act que firmó el presidente Barack Obama el martes 13 de diciembre es un éxito legislativo para la industria farmacéutica. Qué podría pasar con los servicios de medicina preventiva.

Enfermos… ¿y en bancarrota? Consumidores gastarán más en drogas en 2017

KFF Health News Original

En 2017, muchos más planes de salud en los mercados de seguros requerirán que los consumidores paguen una sustancial parte del costo de los medicamentos más caros, dicen, para disuadir a pacientes muy enfermos de elegir sus planes.

Tighter Prescribing Rules: An Anti-Abuse Strategy That Could Hurt Patients In Pain

KFF Health News Original

Responding to a national epidemic, many state Medicaid programs are making the coverage rules for these opioid-based medicines tougher so that physicians will think twice before prescribing them. But some worry that legitimate pain patients could suffer.

Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar

KFF Health News Original

The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.